BOLD
Boundless Bio, Inc.
2.90$
+1.8%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | |
| – | – | – | – | +38.1% | +1.6% | +13.5% | +15.2% | |
| – | – | – | – | – | – | – | – | |
| – | +55.6% | +37.5% | -81.5% | +92.8% | +14.7% | +29.6% | -18.9% | |
| – | +53.2% | +73.7% | -79.9% | +54.6% | +30.6% | +48.0% | +3.9% | |
| – | +55.2% | +44.2% | -81.2% | +83.7% | +17.9% | +31.7% | -13.7% | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | -694.2% | – | -101.7% | – | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.